ASGCT News

Filter By

Recent Articles

Accessing the 2021 Policy Summit

ASGCT Staff | September 21, 2021

Whether you're attending in person or virtually, here's some information that will help you make the most out of the 2021 Policy Summit.

Policy Summit
Read Full Story

Global Gene Therapy Initiative Aims to Bring Gene Therapy Trials to India and Uganda

Jennifer Adair, PhD, and Lindsay Androski, JD, MBA | September 15, 2021

The Global Gene Therapy Initiative (GGTI) recently published its first report in Gene Therapy, which highlights the need for cost-effective gene therapy development strategies in low-and-middle-income countries.

Read Full Story

Comirnaty Becomes First-Ever mRNA Vaccine to Receive FDA Approval

Beverly L. Davidson, PhD | August 27, 2021

ASGCT President Beverly L. Davidson, PhD, discusses this week's FDA approval of the Pfizer-BioNTech vaccine for COVID-19.

Read Full Story

Vaccines Still Offer Protection from Mutated Virus

Eoghan J. Mulholland, Ph.D. | August 19, 2021

To recognize National Immunization Awareness Month, Eoghan Mulholland, PhD, discusses how viruses mutate and what that means for vaccinated people as the delta variant spreads.

Read Full Story

Why I Attend the ASGCT Policy Summit

Emily Walsh Martin, PhD | August 09, 2021

This year's hybrid Policy Summit promises to deliver with key discussions around Medicaid coverage considerations, AAV insertion risk assessment, patient views on therapy opportunities and challenges, and more.

Policy Summit
Read Full Story

ASGCT Impacts Strategic Planning Process for National Institutes of Health

ASGCT Staff | August 04, 2021

Read about ASGCT's impact on the strategic planning processes of the National Eye Institute and the National Institute of Neurological Disorders and Stroke.

Read Full Story

Five Reasons to Apply for the Mentorship Award Program

Rayne Rouce, MD | August 04, 2021

ASGCT Board Member Rayne Rouce, MD, gives five reasons for ASGCT members to apply for the Mentorship Award Program, which is accepting applications through August 31.

Read Full Story

Learn About Gene Therapy for GM1 Gangliosidosis

ASGCT Staff | July 29, 2021

New resources focusing on GM1 gangliosidosis are now available on our Patient Education site!

Education
Read Full Story

Gene, Cell, & RNA Therapy Landscape: Q2 2021

David M. Barrett, J.D., M.S. | July 23, 2021

Highlights in the second quarter of 2021 include the approval of a new gene therapy in Japan, the expansion of gene therapy approvals to three new countries, and more!

Read Full Story

ASGCT Addresses Challenges and Potential Solutions to Development in LMICs

Johnny Mahlangu, BSc, MBBCh, MMed, FCPath  | July 14, 2021

While there has been significant clinical advancement of gene therapy in the US, EU, and Japan, low- and middle-income countries (LMICs) do not have the same access to resources needed for development.

Read Full Story

ASGCT Grapples With Development for Ultra-Rare Diseases

ASGCT Staff | July 01, 2021

Read some highlights from last week's Forum on Gene Therapy for Underserved Populations.

Read Full Story

Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020

ASGCT Staff | July 01, 2021

Molecular Therapy-Oncolytics' 75% increase, to 7.200, was the highest impact factor jump across more than 50 Cell Press journals.

Molecular Therapy
Read Full Story

Twitter for Scientists: Tips from Nicole Paulk, Ph.D.

Catherine Gillespie | June 18, 2021

If you're interested in getting started or becoming more established on Twitter, Nicole Paulk, Ph.D., shared some tips during ASGCT's Academic Writing Dos and Don'ts seminar.

Read Full Story

Getting to Know Ralph Yaniz, LGMD2L Patient and Advocate

Kenji Rowel Lim | June 11, 2021

We talked to Ralph Yaniz about his experience with limb girdle muscular dystrophy type 2L (LGMD2L), his advocacy activities, and more.

Read Full Story

Global Speakers Address Developing Gene Therapies in Low- and Middle-Income Countries

Martín Bonamino, Ph.D. | June 03, 2021

Martín Bonamino, Ph.D., provides a recap of the first Annual Meeting session organized by ASGCT's Global Outreach Committee.

Annual Meeting
Read Full Story

Q&A with Bruce Pyenson

Francesca Cook, MPH | June 03, 2021

ASGCT Government Relations Committee Chair Francesca Cook talked to Bruce Pyenson about reinsurance and risk, U.S. healthcare, and how the system will need to adapt to regenerative therapies.

Annual Meeting
Read Full Story
2021

ASGCT Policy Summit

September 22-24, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.